MDMA ('Ecstasy') and its association with cerebrovascular accidents: Preliminary findings

American Journal of Neuroradiology

Volumn 21, Issue 6, 2000, Pages 1001-1007

  Reneman, Liesbeth ^a   Habraken, Jan B A ^a   Majoie, Charles B L ^a   Booij, Jan ^a   Den Heeten, Gerard J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN; SEROTONIN 2 RECEPTOR;

ADULT; ARTICLE; BRAIN BLOOD VOLUME; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG ABUSE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM;

ADULT; BLOOD VOLUME; CEREBRAL CORTEX; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PIPERIDINES; RECEPTORS, SEROTONIN; REFERENCE VALUES; STREET DRUGS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034045501     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hanyu S, Ikeguchi K, Imai H, Imai N, Yoshida M. Cerebral infarction is associated with 3,4-methylenedioxymethamphetamine ("Ecstasy") abuse. Eur Neurol 1995;35:173
2. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("Ecstasy"). Lancet 1992;340:384-387
3. Harries DP, De Silva R. "Ecstasy" and intracerebral haemorrhage. Scott Med J 1992;37:150-152
4. De Silva RN, Harries DP. Misuse of ecstasy. BMJ 1992;305:310
5. Henry JA. Ecstasy and the dance of death. BMJ 1992;305:5-6
6. Gledhill JA, Moore DF, Bell D, Henry JA. Subarachnoid haemorrhage associated with MDMA abuse. J Neurol Neurosurg Psychiatry 1993;56:1036-1037
7. Hughes JC, McCabe M, Evans RJ. Intracranial haemorrhage associated with ingestion of "ecstasy." Arch Emerg Med 1993; 10:372-374
8. Teggin AF. Ecstasy: a dangerous drug. S Afr Med J 1992;101: 431-432
9. Squier MV, Jalloh S, Hilton-Jones D, Series H. Death after ecstasy ingestion: neuropathological findings. J Neurol Neurosurg Psychiatry 1995;50:756
10. Spatt J, Glawar B, Mamoli B. A pure amnestic syndrome after MDMA ("ecstasy") ingestion. J Neurol Neurosurg Psychiatry 1997;62:418-419
11. Cohen Z, Bonvento G, Lacombe P, Hamel E. Serotonin in the regulation of brain microcirculation. Prog Neurobiol 1996;50: 335-362
12. Parsons AA. 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 1991;12:310-315
13. Green AR, Cross AJ, Goodwin GM. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology 1995; 114:247-260
14. 2A ligand for single-photon emission tomography, in healthy human subjects. Eur J Nucl Med 1997;29:119-124
15. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
16. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990;19:538-546
17. Kaufman MJ, Levin JM, Maas LC, et al. Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study. Psychopharmacology 1998;138:76-81
18. 2 receptors. Neuropharmacology 1992;31:881-893
19. 123I-5-I-R-91150. Br J Psychiatry 1998;173:236-241
20. Ostergaard L, Weiskoff RM, Chesler DA, Gyldensted C, Rosen B. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725
21. Rosen B, Belliveau J, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989;5:263-281
22. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
23. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995;36:520-528
24. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980;210:88-90
25. 2 receptors. Neuropharmacology 1985;24:1201-1205
26. White SR, Obradovic T, Imel KM, Wheaton MJ. The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 1996;49:455-479
27. Scheffel U, Szabo Z, Mathews WB, et al. In vivo detection of short- and long-term MDMA neurotoxicity: a positron emission tomography study in the living baboon brain. Synapse 1998;29:183-192
28. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings. Lancet 1998;352:1433-1437
29. 2 receptors of the human brain postmortem. Brain Res 1990;519: 223-227
30. 2 receptor antagonists and migraine therapy. J Neurol 1991;238:S45-S52
31. Lammertsma AA, Wise RJS, Cox TcS, Thomas DGT, Jones T. Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br J Radiol 1985; 58:725-734
32. Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain, IV: autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987;21:123-139
33. Schotte A, Maloteaux JM, Laduron PM. Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 1983;276:231-235
34. 2A receptors: influence of age and gender in healthy human subjects. Eur J Nucl Med 1998;25:1617-1622